Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial (2024)

Article Navigation

Article Contents

  • Abstract

Journal Article Accepted manuscript

,

P R D Clephas

Department of Cardiology, Thorax centre, Cardiovascular institute, Erasmus University Medical Center

,

Rotterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

V W Zwartkruis

Department of Cardiology, University Medical Centre Groningen

,

Groningen

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

J Malgie

Department of Cardiology, Thorax centre, Cardiovascular institute, Erasmus University Medical Center

,

Rotterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

M W F van Gent

Department of Cardiology, Albert Schweitzer Hospital

,

Dordrecht

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

H P Brunner-La Rocca

Department of Cardiology, Maastricht University Medical Centre

,

Maastricht

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

M K Szymanski

Department of Cardiology, University Medical Center Utrecht

,

Utrecht

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

V P van Halm

Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam

,

Amsterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

M L Handoko

Department of Cardiology, University Medical Center Utrecht

,

Utrecht

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

W Kok

Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam

,

Amsterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

F W Asselbergs

Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam

,

Amsterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

... Show more

,

R van Kimmenade

Department of Cardiology, Radboud University Medical Centre

,

Nijmegen

,

Netherlands

Search for other works by this author on:

Oxford Academic

, ,

N M D A van Mieghem

Department of Cardiology, Thorax centre, Cardiovascular institute, Erasmus University Medical Center

,

Rotterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

S L M A Beeres

Department of Cardiology, Leiden University Medical Centre

,

Leiden

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

M C Post

Department of Cardiology, University Medical Center Utrecht

,

Utrecht

,

Netherlands

Department of Cardiology, St. Antonius Hospital

,

Nieuwegein

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

C J W Borleffs

Department of Cardiology, HAGA Hospital

,

Den Haag

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

R Tukkie

Department of Cardiology, Spaarne Hospital

,

Haarlem

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

A Mosterd

Department of Cardiology, Meander Medical Centre

,

Amersfoort

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

G C M Linssen

Department of Cardiology, Hospital Group Twente

,

Almelo

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

R F Spee

Department of Cardiology, Maxima Medical Centre

,

Veldhoven/Eindhoven

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

M E Emans

Department of Cardiology, Ikazia hospital

,

Rotterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

T D J Smilde

Department of Cardiology, Scheeper Hospital TREANT

,

Emmen

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

J van Ramshorst

Department of Cardiology, Noordwest Hospital group

,

Alkmaar

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

C Kirchhof

Department of Cardiology, Alrijne Hospital

,

Leiderdorp

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

F Feenema–Aardema

Department of Cardiology, Medical Centre Leeuwarden

,

Leeuwarden

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

C A da Fonseca

Department of Cardiology, Medical Centre Leeuwarden

,

Leeuwarden

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

M van den Heuve

Department of Cardiology, Department of Cardiology, Medisch Spectrum Twente

,

Enschede

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

R Hazeleger

Department of Cardiology, Vie Curi Hospital

,

Venlo

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

M van Eck

Department of Cardiology, Jeroen Bosch Hospital, ’s-Hertogenbosch

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

L van Heerebeek

Department of Cardiology, OLVG Hospital

,

Amsterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

H Boersma

Department of Cardiology, Thorax centre, Cardiovascular institute, Erasmus University Medical Center

,

Rotterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

M Rienstra

Department of Cardiology, University Medical Centre Groningen

,

Groningen

,

Netherlands

Search for other works by this author on:

Oxford Academic

,

R A de Boer

Department of Cardiology, Thorax centre, Cardiovascular institute, Erasmus University Medical Center

,

Rotterdam

,

Netherlands

Search for other works by this author on:

Oxford Academic

J J Brugts

Department of Cardiology, Thorax centre, Cardiovascular institute, Erasmus University Medical Center

,

Rotterdam

,

Netherlands

Correspondence to: j.brugts@erasmusmc.nl

Search for other works by this author on:

Oxford Academic

V.W. Zwartkruis and J. Malgie shared second authorship

Author Notes

European Heart Journal, ehae323, https://doi.org/10.1093/eurheartj/ehae323

Published:

11 May 2024

Article history

Received:

08 April 2024

Revision received:

03 May 2024

Accepted:

09 May 2024

Published:

11 May 2024

  • PDF
  • Split View
  • Views
    • Article contents
    • Figures & tables
    • Video
    • Audio
    • Supplementary Data
  • Cite

    Cite

    P R D Clephas, V W Zwartkruis, J Malgie, M W F van Gent, H P Brunner-La Rocca, M K Szymanski, V P van Halm, M L Handoko, W Kok, F W Asselbergs, R van Kimmenade, O Manintveld, N M D A van Mieghem, S L M A Beeres, M C Post, C J W Borleffs, R Tukkie, A Mosterd, G C M Linssen, R F Spee, M E Emans, T D J Smilde, J van Ramshorst, C Kirchhof, F Feenema–Aardema, C A da Fonseca, M van den Heuve, R Hazeleger, M van Eck, L van Heerebeek, H Boersma, M Rienstra, R A de Boer, J J Brugts, Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial, European Heart Journal, 2024;, ehae323, https://doi.org/10.1093/eurheartj/ehae323

    Close

Search

Close

Search

Advanced Search

Search Menu

Abstract

Background and Aims

In patients with chronic heart failure (HF), the MONITOR-HF trial demonstrated the efficacy of pulmonary artery (PA)-guided HF therapy over standard of care in improving quality of life and reducing HF hospitalizations and mean PA pressure. This study aimed to evaluate the consistency of these benefits in relation to clinically relevant subgroups.

Methods

The effect of PA-guided HF therapy was evaluated in the MONITOR-HF trial among predefined subgroups based on age, sex, atrial fibrillation, diabetes mellitus, left ventricular ejection fraction, HF aetiology, cardiac resynchronisation therapy, and implantable cardioverter defibrillator. Outcome measures were based upon significance in the main trial and included quality of life, clinical, and PA pressure endpoints, and were assessed for each subgroup. Differential effects in relation to the subgroups were assessed with interaction terms. Both unadjusted and multiple testing adjusted interaction terms were presented.

Results

The effects of PA monitoring on quality of life, clinical events, and PA pressure were consistent in the predefined subgroups, without any clinically relevant heterogeneity within or across all endpoint categories (all adjusted interaction P-values were nonsignificant). In the unadjusted analysis of the primary endpoint quality-of-life change, weak trends towards a less pronounced effect in older patients (Pinteraction = 0.03; adjusted Pinteraction = 0.33) and diabetics (Pinteraction = 0.01; adjusted Pinteraction = 0.06) were observed. However, these interaction effects did not persist after adjusting for multiple testing.

Conclusions

This subgroup analysis confirmed the consistent benefits of PA-guided HF therapy observed in the MONITOR-HF trial across clinically relevant subgroups, highlighting its efficacy in improving quality of life, clinical, and PA pressure endpoints in chronic HF patients.

Structured Graphical Abstract

Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial (5)

Open in new tabDownload slide

Randomized controlled trial, pulmonary artery pressure, sensor, telemonitoring, subgroups, quality of life

Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial (6) Accepted manuscripts

Accepted manuscripts are PDF versions of the author’s final manuscript, as accepted for publication by the journal but prior to copyediting or typesetting. They can be cited using the author(s), article title, journal title, year of online publication, and DOI. They will be replaced by the final typeset articles, which may therefore contain changes. The DOI will remain the same throughout.

PDF

This content is only available as a PDF.

Author notes

V.W. Zwartkruis and J. Malgie shared second authorship

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Topic:

  • chronic heart failure
  • diabetes mellitus
  • heart failure
  • quality of life
  • pulmonary artery pressure
  • quality improvement
  • surrogate endpoints

Issue Section:

Fast Track Congress

Download all slides

  • Supplementary data

  • Supplementary data

    Advertisem*nt intended for healthcare professionals

    Citations

    Views

    Altmetric

    More metrics information

    Metrics

    Total Views 0

    0 Pageviews

    0 PDF Downloads

    Since 5/12/2024

    Citations

    Powered by Dimensions

    Altmetrics

    ×

    Email alerts

    Article activity alert

    Advance article alerts

    New issue alert

    Receive exclusive offers and updates from Oxford Academic

    Citing articles via

    Google Scholar

    • Latest

    • Most Read

    • Most Cited

    Identification of three mechanistic pathways for iron-deficient heart failure
    Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial
    Left atrial intramural haematoma mimicking a thrombus traversing the interatrial septum following thrombolytic therapy for pulmonary embolism
    Cardiac biomarkers for diagnosing Takotsubo syndrome
    Non-traditional risk factors: built environment assessed by Google Street View, syphilis, and rheumatoid arthritis

    More from Oxford Academic

    Cardiovascular Medicine

    Clinical Medicine

    Medicine and Health

    Books

    Journals

    Advertisem*nt intended for healthcare professionals

    Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial (2024)

    References

    Top Articles
    Latest Posts
    Article information

    Author: Golda Nolan II

    Last Updated:

    Views: 5706

    Rating: 4.8 / 5 (78 voted)

    Reviews: 85% of readers found this page helpful

    Author information

    Name: Golda Nolan II

    Birthday: 1998-05-14

    Address: Suite 369 9754 Roberts Pines, West Benitaburgh, NM 69180-7958

    Phone: +522993866487

    Job: Sales Executive

    Hobby: Worldbuilding, Shopping, Quilting, Cooking, Homebrewing, Leather crafting, Pet

    Introduction: My name is Golda Nolan II, I am a thoughtful, clever, cute, jolly, brave, powerful, splendid person who loves writing and wants to share my knowledge and understanding with you.